Skip to main content
. 2026 Apr 29;18(9):1416. doi: 10.3390/cancers18091416
CA19-9 cancer antigen 19-9
CEA carcinoembryonic antigen
CCR Completeness of Cytoreduction
CRS cytoreductive surgery
DFS disease-free survival
ECOG Eastern Cooperative Oncology Group
EPIC early postoperative intraperitoneal chemotherapy
HIPEC hyperthermic intraperitoneal chemotherapy
IPC intraperitoneal chemotherapy
MRI Magnetic resonance imaging
OS overall survival
PCI Peritoneal Cancer Index